TipRanks on MSN

Incyte’s latest study completion: A step forward in drug interaction insights

Incyte ($INCY) announced an update on their ongoing clinical study. Incyte Corporation has recently completed a clinical study titled An ...
TipRanks on MSN

Galmed Pharmaceuticals’ Aramchol study: Key updates and market implications

Galmed Pharmaceuticals ($GLMD) announced an update on their ongoing clinical study. Galmed Pharmaceuticals is conducting a Phase I open-label ...
Seeking Alpha

Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant Depression Transcript

Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Atai Beckley BPL-003 phase IIb open-label extension ...